JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matthies, A.
Right arrow Articles by Alavi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matthies, A.
Right arrow Articles by Alavi, A.
Journal of Nuclear Medicine Vol. 43 No. 7 871-875
© 2002 by Society of Nuclear Medicine


Clinical Investigations

Dual Time Point 18F-FDG PET for the Evaluation of Pulmonary Nodules

Alexander Matthies, MD, Marc Hickeson, MD, Andrew Cuchiara, PhD and Abass Alavi, MD

Division of Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

18F-FDG PET has reached widespread application in the assessment of pulmonary nodules. This study compares the diagnostic accuracy of standard 18F-FDG PET scanning with those of dual time point 18F-FDG PET scanning. Methods: Thirty-six patients (21 women, 15 men; mean age, 67 y; range, 36–88 y) with 38 known or suspected malignant pulmonary nodules underwent PET of the thorax at 2 time points: scan 1 at 70 min (range, 56–110 min) and scan 2 at 123 min (range, 100–163 min) after the intravenous injection of 2.5 MBq 18F-FDG per kilogram of body weight. All scanning was performed on a dedicated C-PET scanner. The mean interval between the scans was 56 min (range, 49–64 min). Regions of interest were overlaid onto each fully corrected image in the areas of the radiographically known lung densities. The standardized uptake values (SUVs) were calculated for both time points. Results: Surgical pathology and follow-up revealed 19 patients with 20 malignant tumors, whereas 16 patients had benign lesions. The tumor SUVs (mean ± SD) were 3.66 ± 1.95 (scan 1) and 4.43 ± 2.43 (scan 2) (20.5% ± 8.1% increase; P < 0.01). Four of 20 malignant tumors had SUVs of <2.5 on scan 1 (range, 1.12–1.69). Benign lesions had SUVs of 1.14 ± 0.64 (scan 1) and 1.11 ± 0.70 (scan 2) (P = not significant). Standard PET scanning (single time point) with a threshold SUV of 2.5 (at time point 1) reached a sensitivity of 80% and a specificity of 94%; dual time point scanning with a threshold value of 10% increase between scan 1 and scan 2 reached a sensitivity of 100% with a specificity of 89%. Conclusion: Dual time point 18F-FDG PET results in a very high sensitivity and specificity for detection of malignant lung tumors.

Key Words: PET • 18F-FDG • lung nodules • metabolism • dual time point




This article has been cited by other articles:


Home page
JNMHome page
R. J. Hicks
Time and Again, Children Resemble Their Parents
J. Nucl. Med., October 1, 2008; 49(10): 1577 - 1578.
[Full Text] [PDF]


Home page
JNMHome page
D. Uesaka, Y. Demura, T. Ishizaki, S. Ameshima, I. Miyamori, M. Sasaki, Y. Fujibayashi, and H. Okazawa
Evaluation of Dual-Time-Point 18F-FDG PET for Staging in Patients with Lung Cancer
J. Nucl. Med., October 1, 2008; 49(10): 1606 - 1612.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C.-J. Chen, B.-F. Lee, W.-J. Yao, L. Cheng, P.-S. Wu, C. L. Chu, and N.-T. Chiu
Dual-Phase 18F-FDG PET in the Diagnosis of Pulmonary Nodules with an Initial Standard Uptake Value Less Than 2.5
Am. J. Roentgenol., August 1, 2008; 191(2): 475 - 479.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. M. Wahidi, J. A. Govert, R. K. Goudar, M. K. Gould, and D. C. McCrory
Evidence for the Treatment of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 94S - 107S.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
D. A. Torigian, S. S. Huang, M. Houseni, and A. Alavi
Functional Imaging of Cancer with Emphasis on Molecular Techniques
CA Cancer J Clin, July 1, 2007; 57(4): 206 - 224.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. M. Blodgett, C. C. Meltzer, and D. W. Townsend
PET/CT: Form and Function
Radiology, February 1, 2007; 242(2): 360 - 385.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Mavi, M. Urhan, J. Q. Yu, H. Zhuang, M. Houseni, T. F. Cermik, D. Thiruvenkatasamy, B. Czerniecki, M. Schnall, and A. Alavi
Dual Time Point 18F-FDG PET Imaging Detects Breast Cancer with High Sensitivity and Correlates Well with Histologic Subtypes
J. Nucl. Med., September 1, 2006; 47(9): 1440 - 1446.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
N. Avril
18F-FDG PET After Radiofrequency Ablation: Is Timing Everything?
J. Nucl. Med., August 1, 2006; 47(8): 1235 - 1237.
[Full Text] [PDF]


Home page
JNMHome page
Y. Nishiyama, Y. Yamamoto, K. Fukunaga, N. Kimura, A. Miki, Y. Sasakawa, H. Wakabayashi, K. Satoh, and M. Ohkawa
Dual-Time-Point 18F-FDG PET for the Evaluation of Gallbladder Carcinoma
J. Nucl. Med., April 1, 2006; 47(4): 633 - 638.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Bunyaviroch and R. E. Coleman
PET Evaluation of Lung Cancer
J. Nucl. Med., March 1, 2006; 47(3): 451 - 469.
[Full Text] [PDF]


Home page
JNMHome page
R. Kumar, V. A. Loving, A. Chauhan, H. Zhuang, S. Mitchell, and A. Alavi
Potential of Dual-Time-Point Imaging to Improve Breast Cancer Diagnosis with 18F-FDG PET
J. Nucl. Med., November 1, 2005; 46(11): 1819 - 1824.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
U. Nestle, S. Kremp, A. Schaefer-Schuler, C. Sebastian-Welsch, D. Hellwig, C. Rube, and C.-M. Kirsch
Comparison of Different Methods for Delineation of 18F-FDG PET-Positive Tissue for Target Volume Definition in Radiotherapy of Patients with Non-Small Cell Lung Cancer
J. Nucl. Med., August 1, 2005; 46(8): 1342 - 1348.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. J. Reinhardt, H. Strunk, T. Gerhardt, R. Roedel, U. Jaeger, J. Bucerius, T. Sauerbruch, H.-J. Biersack, and F. L. Dumoulin
Detection of Klatskin's Tumor in Extrahepatic Bile Duct Strictures Using Delayed 18F-FDG PET/CT: Preliminary Results for 22 Patient Studies
J. Nucl. Med., July 1, 2005; 46(7): 1158 - 1163.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. M. Spence, M. Muzi, D. A. Mankoff, S. F. O'Sullivan, J. M. Link, T. K. Lewellen, B. Lewellen, P. Pham, S. Minoshima, K. Swanson, et al.
18F-FDG PET of Gliomas at Delayed Intervals: Improved Distinction Between Tumor and Normal Gray Matter
J. Nucl. Med., October 1, 2004; 45(10): 1653 - 1659.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. L. Aquino and A. J. Fischman
Does Whole-Body 2-[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Have an Advantage Over Thoracic Positron Emission Tomography for Staging Patients With Lung Cancer?
Chest, September 1, 2004; 126(3): 755 - 760.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. M. Rohren, T. G. Turkington, and R. E. Coleman
Clinical Applications of PET in Oncology
Radiology, May 1, 2004; 231(2): 305 - 332.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. G. Strauss, A. Dimitrakopoulou-Strauss, and U. Haberkorn
Shortened PET Data Acquisition Protocol for the Quantification of 18F-FDG Kinetics
J. Nucl. Med., December 1, 2003; 44(12): 1933 - 1939.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
V H Gerbaudo, S Britz-Cunningham, D J Sugarbaker, and S T Treves
Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma
Thorax, December 1, 2003; 58(12): 1077 - 1082.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S.-Y. Ma, L.-C. See, C.-H. Lai, H.-H. Chou, C.-S. Tsai, K.-K. Ng, S. Hsueh, W.-J. Lin, J.-T. Chen, and T.-C. Yen
Delayed 18F-FDG PET for Detection of Paraaortic Lymph Node Metastases in Cervical Cancer Patients
J. Nucl. Med., November 1, 2003; 44(11): 1775 - 1783.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T.-C. Yen, K.-K. Ng, S.-Y. Ma, H.-H. Chou, C.-S. Tsai, S. Hsueh, T.-C. Chang, J.-H. Hong, L.-C. See, W.-J. Lin, et al.
Value of Dual-Phase 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Cervical Cancer
J. Clin. Oncol., October 1, 2003; 21(19): 3651 - 3658.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Beaulieu, P. Kinahan, J. Tseng, L. K. Dunnwald, E. K. Schubert, P. Pham, B. Lewellen, and D. A. Mankoff
SUV Varies with Time After Injection in 18F-FDG PET of Breast Cancer: Characterization and Method to Adjust for Time Differences
J. Nucl. Med., July 1, 2003; 44(7): 1044 - 1050.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y. Demura, T. Tsuchida, T. Ishizaki, S. Mizuno, Y. Totani, S. Ameshima, I. Miyamori, M. Sasaki, and Y. Yonekura
18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax
J. Nucl. Med., April 1, 2003; 44(4): 540 - 548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.